Pharmaceutical

AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership

AstraZeneca will advance preclinical and clinical development of the Type 1 Diabetes cell therapy candidate.

Nov 19, 2024 - 06:00
AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership
AstraZeneca will advance preclinical and clinical development of the Type 1 Diabetes cell therapy candidate.
Read the original article

Tags:

Previous Article

CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC

Next Article

Intellia’s gene editing therapy shows early potential in rare heart condition

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biden launches a new push to limit health care costs, hoping to show he can save money for families

Biden launches a new push to limit health care costs, h...

Jul 8, 2023

AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting

AstraZeneca wins approval for Imfinzi in NSCLC perioper...

Aug 17, 2024

Opinion: Listen: Living in cancer limbo

Opinion: Listen: Living in cancer limbo

Nov 23, 2023